The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Serological Transplant Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
The global Serological Transplant Diagnostics market size is expected to reach US$ 405.7 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Serological Transplant Diagnostics in various end use industries. The expanding demands from the Hospitals, Blood Banks and Transplant Centers and Donor Registries and Research Laboratories, are propelling Serological Transplant Diagnostics market. Kidney Transplantation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver Transplantation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Serological Transplant Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Serological Transplant Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Serological Transplant Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Serological Transplant Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Serological Transplant Diagnostics covered in this report include Bio-Rad Laboratories, Immucor, Siemens Healthineers, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Agena Bioscience, AVIOQ, BAG Healthcare and BD, etc.
The global Serological Transplant Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Global Serological Transplant Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Serological Transplant Diagnostics market, Segment by Type:
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Global Serological Transplant Diagnostics market, by Application
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Serological Transplant Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.
The global Serological Transplant Diagnostics market size is expected to reach US$ 405.7 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Serological Transplant Diagnostics in various end use industries. The expanding demands from the Hospitals, Blood Banks and Transplant Centers and Donor Registries and Research Laboratories, are propelling Serological Transplant Diagnostics market. Kidney Transplantation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver Transplantation segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Serological Transplant Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Serological Transplant Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Serological Transplant Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Serological Transplant Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Serological Transplant Diagnostics covered in this report include Bio-Rad Laboratories, Immucor, Siemens Healthineers, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Agena Bioscience, AVIOQ, BAG Healthcare and BD, etc.
The global Serological Transplant Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group
Global Serological Transplant Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Serological Transplant Diagnostics market, Segment by Type:
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Global Serological Transplant Diagnostics market, by Application
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Serological Transplant Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Serological Transplant Diagnostics
1.1 Serological Transplant Diagnostics Market Overview
1.1.1 Serological Transplant Diagnostics Product Scope
1.1.2 Serological Transplant Diagnostics Market Status and Outlook
1.2 Global Serological Transplant Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Serological Transplant Diagnostics Market Size by Region (2018-2029)
1.4 Global Serological Transplant Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Serological Transplant Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Serological Transplant Diagnostics Market Size (2018-2029)
1.6.1 North America Serological Transplant Diagnostics Market Size (2018-2029)
1.6.2 Europe Serological Transplant Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Serological Transplant Diagnostics Market Size (2018-2029)
1.6.4 Latin America Serological Transplant Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Serological Transplant Diagnostics Market Size (2018-2029)
2 Serological Transplant Diagnostics Market by Type
2.1 Introduction
2.1.1 Kidney Transplantation
2.1.2 Liver Transplantation
2.1.3 Heart Transplantation
2.1.4 Lung Transplantation
2.1.5 Pancreas Transplantation
2.2 Global Serological Transplant Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Serological Transplant Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Serological Transplant Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Serological Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Serological Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Serological Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Serological Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Serological Transplant Diagnostics Revenue Breakdown by Type (2018-2029)
3 Serological Transplant Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals, Blood Banks and Transplant Centers
3.1.2 Donor Registries and Research Laboratories
3.2 Global Serological Transplant Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Serological Transplant Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Serological Transplant Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Serological Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Serological Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Serological Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Serological Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Serological Transplant Diagnostics Revenue Breakdown by Application (2018-2029)
4 Serological Transplant Diagnostics Competition Analysis by Players
4.1 Global Serological Transplant Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Serological Transplant Diagnostics as of 2022)
4.3 Date of Key Players Enter into Serological Transplant Diagnostics Market
4.4 Global Top Players Serological Transplant Diagnostics Headquarters and Area Served
4.5 Key Players Serological Transplant Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Serological Transplant Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad Laboratories
5.1.1 Bio-Rad Laboratories Profile
5.1.2 Bio-Rad Laboratories Main Business
5.1.3 Bio-Rad Laboratories Serological Transplant Diagnostics Products, Services and Solutions
5.1.4 Bio-Rad Laboratories Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Laboratories Recent Developments
5.2 Immucor
5.2.1 Immucor Profile
5.2.2 Immucor Main Business
5.2.3 Immucor Serological Transplant Diagnostics Products, Services and Solutions
5.2.4 Immucor Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Immucor Recent Developments
5.3 Siemens Healthineers
5.3.1 Siemens Healthineers Profile
5.3.2 Siemens Healthineers Main Business
5.3.3 Siemens Healthineers Serological Transplant Diagnostics Products, Services and Solutions
5.3.4 Siemens Healthineers Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Ortho Clinical Diagnostics Recent Developments
5.4 Ortho Clinical Diagnostics
5.4.1 Ortho Clinical Diagnostics Profile
5.4.2 Ortho Clinical Diagnostics Main Business
5.4.3 Ortho Clinical Diagnostics Serological Transplant Diagnostics Products, Services and Solutions
5.4.4 Ortho Clinical Diagnostics Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Ortho Clinical Diagnostics Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Serological Transplant Diagnostics Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Agena Bioscience
5.6.1 Agena Bioscience Profile
5.6.2 Agena Bioscience Main Business
5.6.3 Agena Bioscience Serological Transplant Diagnostics Products, Services and Solutions
5.6.4 Agena Bioscience Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Agena Bioscience Recent Developments
5.7 AVIOQ
5.7.1 AVIOQ Profile
5.7.2 AVIOQ Main Business
5.7.3 AVIOQ Serological Transplant Diagnostics Products, Services and Solutions
5.7.4 AVIOQ Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 AVIOQ Recent Developments
5.8 BAG Healthcare
5.8.1 BAG Healthcare Profile
5.8.2 BAG Healthcare Main Business
5.8.3 BAG Healthcare Serological Transplant Diagnostics Products, Services and Solutions
5.8.4 BAG Healthcare Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 BAG Healthcare Recent Developments
5.9 BD
5.9.1 BD Profile
5.9.2 BD Main Business
5.9.3 BD Serological Transplant Diagnostics Products, Services and Solutions
5.9.4 BD Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 BD Recent Developments
5.10 Beckman Coulter
5.10.1 Beckman Coulter Profile
5.10.2 Beckman Coulter Main Business
5.10.3 Beckman Coulter Serological Transplant Diagnostics Products, Services and Solutions
5.10.4 Beckman Coulter Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Beckman Coulter Recent Developments
5.11 Biogenuix
5.11.1 Biogenuix Profile
5.11.2 Biogenuix Main Business
5.11.3 Biogenuix Serological Transplant Diagnostics Products, Services and Solutions
5.11.4 Biogenuix Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Biogenuix Recent Developments
5.12 DIAGAST
5.12.1 DIAGAST Profile
5.12.2 DIAGAST Main Business
5.12.3 DIAGAST Serological Transplant Diagnostics Products, Services and Solutions
5.12.4 DIAGAST Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 DIAGAST Recent Developments
5.13 Grifols
5.13.1 Grifols Profile
5.13.2 Grifols Main Business
5.13.3 Grifols Serological Transplant Diagnostics Products, Services and Solutions
5.13.4 Grifols Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.13.5 Grifols Recent Developments
5.14 Hemo bioscience
5.14.1 Hemo bioscience Profile
5.14.2 Hemo bioscience Main Business
5.14.3 Hemo bioscience Serological Transplant Diagnostics Products, Services and Solutions
5.14.4 Hemo bioscience Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.14.5 Hemo bioscience Recent Developments
5.15 Institut de Biotechnologies
5.15.1 Institut de Biotechnologies Profile
5.15.2 Institut de Biotechnologies Main Business
5.15.3 Institut de Biotechnologies Serological Transplant Diagnostics Products, Services and Solutions
5.15.4 Institut de Biotechnologies Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.15.5 Institut de Biotechnologies Recent Developments
5.16 Lorne Laboratories
5.16.1 Lorne Laboratories Profile
5.16.2 Lorne Laboratories Main Business
5.16.3 Lorne Laboratories Serological Transplant Diagnostics Products, Services and Solutions
5.16.4 Lorne Laboratories Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.16.5 Lorne Laboratories Recent Developments
5.17 MTC Invitro
5.17.1 MTC Invitro Profile
5.17.2 MTC Invitro Main Business
5.17.3 MTC Invitro Serological Transplant Diagnostics Products, Services and Solutions
5.17.4 MTC Invitro Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.17.5 MTC Invitro Recent Developments
5.18 Quotient Biodiagnostics
5.18.1 Quotient Biodiagnostics Profile
5.18.2 Quotient Biodiagnostics Main Business
5.18.3 Quotient Biodiagnostics Serological Transplant Diagnostics Products, Services and Solutions
5.18.4 Quotient Biodiagnostics Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.18.5 Quotient Biodiagnostics Recent Developments
5.19 Tulip Group
5.19.1 Tulip Group Profile
5.19.2 Tulip Group Main Business
5.19.3 Tulip Group Serological Transplant Diagnostics Products, Services and Solutions
5.19.4 Tulip Group Serological Transplant Diagnostics Revenue (US$ Million) & (2018-2023)
5.19.5 Tulip Group Recent Developments
6 North America
6.1 North America Serological Transplant Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Serological Transplant Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Serological Transplant Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Serological Transplant Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Serological Transplant Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Serological Transplant Diagnostics Market Dynamics
11.1 Serological Transplant Diagnostics Industry Trends
11.2 Serological Transplant Diagnostics Market Drivers
11.3 Serological Transplant Diagnostics Market Challenges
11.4 Serological Transplant Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
